Biotech Values

[DewDiligence]

It seems either a strategy change or perhaps insight into the challenges of their present discussions with partners for the FoB program who may be playing hardball?

There is a no change in MNTA’s FoB strategy per se, but there’s a change in what MNTA is seeking from an FoB partner. Thanks to MNTA’s $300M+ cash balance and strong cash flow from operations, MNTA no longer needs an FoB partnership for the partner’s cash; MNTA does, however, need an FoB partnership for the partner’s commercialization expertise. This makes the FoB-partnership negotiations rather different than they would be if MNTA were primarily looking for cash. Regards, Dew